A Randomized, Placebo-controlled, Double-blind Clinical Trial of Bacteriophage Cocktails in Chronic Wound Infections
The International Journal of Lower Extremity Wounds · 2026-06 · 25 (2) · 427-437
DOI: 10.1177/15347346231226342 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The International Journal of Lower Extremity Wounds, online erschienen am 17.01.2024. Verfasst von Subhash Lal Karn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Hauptthemen laut MEDLINE: Phage Therapy, Wound Infection, Bacteriophages. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic wounds are prevalent globally at endemic proportions. The common features associated with chronic wounds are prolonged inflammatory phase, infection with multidrug-resistant (MDR) bacteria, and subsequent biofilm formation. The present randomized-controlled trial (RCT) study was undertaken on chronic wounds of ≥6 weeks longer duration using customized phages to evaluate the efficacy and safety of bacteriophage therapy.
Methods
The study was conducted from December 2021 to August 2023. Thirty patients in each of the arms (placebo and bacteriophage) were recruited with chronic wounds. The patients, both arms, received the conventional treatment of wound debridement, local antiseptics, and local and systemic antibiotics at the discretion of the treating surgeon. However, before applying the customized bacteriophage cocktail or placebo, the wound surface was thoroughly washed to remove the residual antiseptics. The phage cocktails or placebo were applied on alternate days. The wounds were evaluated using the Bates-Jensen Wound Assessment Tool for the progress of wound healing.
Results
A total of 93.3% of the wound became sterile in 39 days (median sterility time), followed by complete healing by the end of 90 days in the phage group. Contrary to this, 83.3% of those on placebo therapy remained colonized by original bacteria or additional new bacteria without healing for up to 90 days.
Conclusion
With the well-designed RCT, we could conclude that customized bacteriophage therapy using bacteriophage cocktails will definitely cure the chronic wound, irrespective of age, sex, diabetes status, and infection by MDR bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
- Department of General Surgery, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi India.
ORCID-Profile: Subhash Lal Karn, Mayank Gangwar, Gopal Nath
Zitieren
APA
Karn, S. L., Bhartiya, S. K., Pratap, A., Saroj, S. K., Kumar, R., Sahu, M., Gangwar, M., & Nath, G. (2026). A Randomized, Placebo-controlled, Double-blind Clinical Trial of Bacteriophage Cocktails in Chronic Wound Infections. The International Journal of Lower Extremity Wounds, 25(2), 427-437. https://doi.org/10.1177/15347346231226342
Vancouver
Karn SL, Bhartiya SK, Pratap A, Saroj SK, Kumar R, Sahu M, et al. A Randomized, Placebo-controlled, Double-blind Clinical Trial of Bacteriophage Cocktails in Chronic Wound Infections. The International Journal of Lower Extremity Wounds. 2026;25(2):427-437. doi:10.1177/15347346231226342
BibTeX
@article{Karn2026,
author = {Karn, Subhash Lal and Bhartiya, Satyanam Kumar and Pratap, Arvind and Saroj, Sanjay Kumar and Kumar, Rajesh and Sahu, Minakshi and Gangwar, Mayank and Nath, Gopal},
title = {A Randomized, Placebo-controlled, Double-blind Clinical Trial of Bacteriophage Cocktails in Chronic Wound Infections},
journal = {The International Journal of Lower Extremity Wounds},
year = {2026},
volume = {25},
number = {2},
pages = {427--437},
doi = {10.1177/15347346231226342}
}
EUVIMED